Chemotherapy (Quality of Life)

Shortened Drug-Delivery Schedule Increases Neurotoxicity

Published in Cancer Weekly, August 19th, 1996

A study released in the August 7, 1996, issue of the journal Gynecologic Oncology suggests that shortening the infusion time of paclitaxel (taxol) when given with cisplatin chemotherapy increases the incidence of peripheral nerve damage - often severely affecting the use of patients' hands and feet.

These potent chemotherapy drugs are standard treatment for conditions such as ovarian cancer. Debate has surrounded how to best administer these agents in order to maximize their effectiveness while minimizing their toxicity.

Recent economic pressures from insurance companies have favored the use of a shorter chemotherapy infusion time and an outpatient...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cancer Weekly

Source: Cancer Weekly (1996-08-19)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry